Literature DB >> 4069310

Transport of pipecolic acid in adult and developing mouse brain.

J S Kim, E Giacobini.   

Abstract

In an effort to develop an animal model of hyperpipecolatemia, the uptake of pipecolic acid (PA) in the brain and changes of PA levels in serum following administration of D,L-PA were studied in the mouse using a new sensitive HPLC-EC method. Following i.p. injections (250 mg/kg) to adult male mice, the brain concentration peaks at 5-10 min (40 nmol/g). The level remains relatively stable up to 5 hrs and then declines slowly to 24 hrs. In serum, the level of PA increases rapidly to reach the maximum value at 10 min and then decreases rapidly in the first hour and continues to decline more slowly to 24 hrs. The net uptake of PA following administration of various amounts of D,L-PA is saturable at low doses (3.9-15.6 mg/kg), and it increases linearly at higher doses in a dose-dependent manner up to the maximum dose (500 mg/kg) used in the present study. Kinetic analysis suggests the presence of two kinds of transport systems. These findings are in good agreement with the previous results using D,L-[3H]PA in the mouse (7) and L-[14C]PA in the rat (13). There were no significant differences between uptake of D-pipecolic acid and L-pipecolic acid (250 mg/kg, i.p., 10 min), suggesting the absence of stereospecificity for PA uptake in the mouse brain. Developmental changes in net brain uptake of PA following injections of D,L-PA (250 mg/kg, s.c., 10 min) showed an age-dependent decrease which continues until adult levels are reached at four weeks after birth. The results suggest that the blood brain barrier (BBB) for PA is completed during the first month of life. Following administration of D,L-PA (250 mg/kg, s.c.) to pregnant mice during the period 19-21 days of gestation, PA level increases in fetal brain to a maximum value at 2 hrs (420 nmol/g). This level is unchanged during 24 hrs. The maximum level of PA in fetal serum is reached at 30 min to 1 hr. The level gradually decreases after 1 hr over 24 hrs. These results indicate that PA taken up by the placenta and into the brain is transported from the fetal circulation.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4069310     DOI: 10.1007/BF00964981

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  20 in total

1.  Cerebro-hepato-renal syndrome of Zellweger. A report of eight cases with comments upon the incidence, the liver lesion, and a fault in pipecolic acid metabolism.

Authors:  D M Danks; P Tippett; C Adams; P Campbell
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

2.  Capillary transport of amino acids in the developing brain.

Authors:  H Sershen; A Lajtha
Journal:  Exp Neurol       Date:  1976-11       Impact factor: 5.330

3.  Pipecolic acid: origin, biosynthesis and metabolism in the brain.

Authors:  E Giacobini; Y Nomura; T Schmidt-Glenewinkel
Journal:  Cell Mol Biol Incl Cyto Enzymol       Date:  1980

4.  Metabolism and uptake of L-pipecolic acid by brain and heart.

Authors:  A K Charles; Y F Chang
Journal:  Life Sci       Date:  1981-08-31       Impact factor: 5.037

5.  Pipecolic acid levels and transport in developing mouse brain.

Authors:  J S Kim; E Giacobini
Journal:  Brain Res       Date:  1985-10       Impact factor: 3.252

6.  Developmental modulations of blood-brain barrier permeability as an indicator of changing nutritional requirements in the brain.

Authors:  E M Cornford; L D Braun; W H Oldendorf
Journal:  Pediatr Res       Date:  1982-04       Impact factor: 3.756

7.  Quantitative determination and regional distribution of pipecolic acid in rodent brain.

Authors:  J S Kim; E Giacobini
Journal:  Neurochem Res       Date:  1984-11       Impact factor: 3.996

8.  Hyperpipecolic acidemia in neonatal adrenoleukodystrophy.

Authors:  R I Kelley; H W Moser
Journal:  Am J Med Genet       Date:  1984-12

9.  The effects of hyperphenylalaninemia on fetal development: a new animal model of maternal phenylketonuria.

Authors:  C A Brass; C E Isaacs; R McChesney; O Greengard
Journal:  Pediatr Res       Date:  1982-05       Impact factor: 3.756

10.  Peroxisomal defects in neonatal-onset and X-linked adrenoleukodystrophies.

Authors:  S Goldfischer; J Collins; I Rapin; B Coltoff-Schiller; C H Chang; M Nigro; V H Black; N B Javitt; H W Moser; P B Lazarow
Journal:  Science       Date:  1985-01-04       Impact factor: 47.728

View more
  1 in total

1.  Pipecolic Acid, a Putative Mediator of the Encephalopathy of Cerebral Malaria and the Experimental Model of Cerebral Malaria.

Authors:  Tarun Keswani; Aisha Obeidallah; Edward Nieves; Simone Sidoli; Melissa Fazzari; Terrie Taylor; Karl Seydel; Johanna P Daily
Journal:  J Infect Dis       Date:  2022-02-15       Impact factor: 5.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.